Citation: Kumar V, Hertz M, Agro A and Byrne AJ (2023) Type 1 invariant natural killer T cells in chronic inflammation and tissue fibrosis. Front. Immunol. 14:1260503. doi: 10.3389/fimmu.2023.1260503 Chronic tissue inflammation often results in fibrosis characterized by the accumulation of extracellular matrix components remodeling normal tissue architecture and function. Recent studies have suggested common immune mechanisms despite […]
Tag: fibrosis
Recent Posts
- This PF Awareness Month, Action for Pulmonary Fibrosis is asking everyone to Take Action for PF.
- Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis
- Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction
- September is Pulmonary Fibrosis Awareness Month
- The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis
- Type 1 invariant natural killer T cells in chronic inflammation and tissue fibrosis
- September is Pulmonary Fibrosis (PF) Awareness Month
- Exercise training in idiopathic pulmonary fibrosis: is it of benefit?
- Evaluation for clinical benefit of metformin in patients with idiopathic pulmonary fibrosisand type 2 diabetes mellitus: a national claims‑based cohort analysis
- Plasticity towards Rigidity: A Macrophage Conundrum in
Pulmonary Fibrosis - TIPAL
- Targeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling
- Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
- Mitochondrial Quality Control in COPD and IPF
- Idiopathic Pulmonary Fibrosis (IPF): An Overview
- UK Petition, March 2023
- Pulmonary Fibrosis Research and Education Hub
- Hello world!
Recent Comments
No comments to show.
